Gharpure A, Noviello C, Hibbs R
Neuropharmacology. 2020; 171:108086.
PMID: 32272141
PMC: 7255940.
DOI: 10.1016/j.neuropharm.2020.108086.
Crooks P, Bardo M, Dwoskin L
Adv Pharmacol. 2014; 69:513-51.
PMID: 24484986
PMC: 4110698.
DOI: 10.1016/B978-0-12-420118-7.00013-5.
Proulx E, Piva M, Tian M, Bailey C, Lambe E
Cell Mol Life Sci. 2013; 71(7):1225-44.
PMID: 24122021
PMC: 3949016.
DOI: 10.1007/s00018-013-1481-3.
Stanchev D, Sargent P
J Neurosci. 2011; 31(42):14920-30.
PMID: 22016525
PMC: 3342687.
DOI: 10.1523/JNEUROSCI.3400-11.2011.
Marks M, McClure-Begley T, Whiteaker P, Salminen O, Brown R, Cooper J
J Pharmacol Exp Ther. 2011; 337(1):187-200.
PMID: 21228066
PMC: 3063733.
DOI: 10.1124/jpet.110.178236.
Quantitative analysis of the heteromeric neuronal nicotinic receptors in the rat hippocampus.
Lomazzo E, Macarthur L, Yasuda R, Wolfe B, Kellar K
J Neurochem. 2010; 115(3):625-34.
PMID: 20796176
PMC: 2976603.
DOI: 10.1111/j.1471-4159.2010.06967.x.
The cholinergic system and Parkinson disease.
Bohnen N, Albin R
Behav Brain Res. 2010; 221(2):564-73.
PMID: 20060022
PMC: 2888997.
DOI: 10.1016/j.bbr.2009.12.048.
Cellular events in nicotine addiction.
Penton R, Lester R
Semin Cell Dev Biol. 2009; 20(4):418-31.
PMID: 19560047
PMC: 2704462.
DOI: 10.1016/j.semcdb.2009.01.001.
Nicotinic receptor-based therapeutics and candidates for smoking cessation.
Dwoskin L, Smith A, Wooters T, Zhang Z, Crooks P, Bardo M
Biochem Pharmacol. 2009; 78(7):732-43.
PMID: 19523455
PMC: 4110684.
DOI: 10.1016/j.bcp.2009.06.002.
Nicotinic receptors concentrated in the subsynaptic membrane do not contribute significantly to synaptic currents at an embryonic synapse in the chicken ciliary ganglion.
Sargent P
J Neurosci. 2009; 29(12):3749-59.
PMID: 19321771
PMC: 2696354.
DOI: 10.1523/JNEUROSCI.5404-08.2009.
Mammalian nicotinic acetylcholine receptors: from structure to function.
Albuquerque E, Pereira E, Alkondon M, Rogers S
Physiol Rev. 2009; 89(1):73-120.
PMID: 19126755
PMC: 2713585.
DOI: 10.1152/physrev.00015.2008.
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.
Dwoskin L, Pivavarchyk M, Joyce B, Neugebauer N, Zheng G, Zhang Z
Nebr Symp Motiv. 2008; 55:31-63.
PMID: 19013938
PMC: 3090004.
DOI: 10.1007/978-0-387-78748-0_4.
Identification of pharmacogenetic markers in smoking cessation therapy.
Heitjan D, Guo M, Ray R, Wileyto E, Epstein L, Lerman C
Am J Med Genet B Neuropsychiatr Genet. 2008; 147B(6):712-9.
PMID: 18165968
PMC: 2655206.
DOI: 10.1002/ajmg.b.30669.
Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders.
Bohnen N, Frey K
Mol Imaging Biol. 2007; 9(4):243-57.
PMID: 17318670
DOI: 10.1007/s11307-007-0083-6.
Stoichiometry of the alpha9alpha10 nicotinic cholinergic receptor.
Plazas P, Katz E, Gomez-Casati M, Bouzat C, Elgoyhen A
J Neurosci. 2005; 25(47):10905-12.
PMID: 16306403
PMC: 6725887.
DOI: 10.1523/JNEUROSCI.3805-05.2005.
Nicotinic cholinergic receptors in the rat cerebellum: multiple heteromeric subtypes.
Turner J, Kellar K
J Neurosci. 2005; 25(40):9258-65.
PMID: 16207885
PMC: 6725767.
DOI: 10.1523/JNEUROSCI.2112-05.2005.
Nicotinic cholinergic modulation: galantamine as a prototype.
Woodruff-Pak D, Lander C, Geerts H
CNS Drug Rev. 2002; 8(4):405-26.
PMID: 12481195
PMC: 6741680.
DOI: 10.1111/j.1527-3458.2002.tb00237.x.
Autonomic function in mice lacking alpha5 neuronal nicotinic acetylcholine receptor subunit.
Wang N, Orr-Urtreger A, Chapman J, Rabinowitz R, Nachman R, Korczyn A
J Physiol. 2002; 542(Pt 2):347-54.
PMID: 12122136
PMC: 2316148.
DOI: 10.1113/jphysiol.2001.013456.
The neuronal nicotinic acetylcholine receptor in some hereditary epilepsies.
Barrantes F, Aztiria E, Rauschemberger M, Vasconsuelo A
Neurochem Res. 2000; 25(5):583-90.
PMID: 10905619
DOI: 10.1023/a:1007594516465.
Cell type-specific activation of neuronal nicotinic acetylcholine receptor subunit genes by Sox10.
Liu Q, Melnikova I, Hu M, Gardner P
J Neurosci. 1999; 19(22):9747-55.
PMID: 10559384
PMC: 6782953.